from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2422/-

LFCtreatmentdescriptionclass of inhibitor

0.350

Amikacinug/mL Amikacintranslation

0.477

Cap5-10ug/mL Capreomycintranslation

-0.607

Rox10-50 ug/mL Roxithromycintranslation

-0.887

SM2-5 ug/mL Streptomycintranslation

0.530

Tet5-10 ug/mL Tetracyclinetranslation

-0.359

Rif0.2-5ug/mL Rifampicintranscription

0.323

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.100

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.921

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.232

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.747

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.393

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.107

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.823

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.268

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.213

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.382

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.308

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.076

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.113

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.344

KCN5-20 ug/mL Potassium cyaniderespiration

-0.381

NaN30.2-2 mM Sodium aziderespiration

-0.256

Nigericin50 uM Nigericinrespiration

-0.011

TRC10-150 ug/mL Triclosanrespiration

0.781

TRZ10-25 ug/mL Thioridazinerespiration

-1.430

Valinomycin0.5-10 uM Valinomycinrespiration

-0.693

ZnSO42 mM ZnSO4respiration

-0.837

menadione6-10 ug/mL Menadionerespiration

0.247

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.860

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.015

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.217

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.829

NRP_1Non-replicating persistence stage 1dosRassociated

-0.582

Amp0.2mg/mL AmpicillincellWall

0.086

Cephalexin20-100 ug/mL CephalexincellWall

-0.871

Cerulenin0.32-5 ug/mL CerulenincellWall

-2.191

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.947

EMB10-20 ug/mL EthambutolcellWall

-0.722

Eta12-40 ug/mL EthionamidecellWall

-0.575

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.544

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.367

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.612

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.644

BZA0.12 mg/mL BenzamidearomaticAmides

0.454

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.545

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.128

H2O24 mM hydrogen peroxideDNAdamaging

-0.087

Levo10 ug/mL LevofloxacinDNAdamaging

0.863

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.074

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.537

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.762

UVUV-irradiationDNAdamaging

1.636

ARP41-4 ug/mL Antitubercular compound ARP4?

0.344

Antimycin12.5-50 ug/mL Antimycin A?

-0.833

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.126

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.366

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.471

PA8240.2-2 ug/mL PA-824?

-0.694

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.006

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.049

Verapamil50 uM Verapamil?

0.387

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.423

methoxatin10-20 ug/mL Methoxatin?